Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

SGTX Sigilon Therapeutics Inc

22,47

0,00 (0,00%)

09 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Sigilon Therapeutics (NASDAQ:SGTX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Sigilon Therapeutics Charts.

Sigilon Therapeutics (NASDAQ:SGTX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Sigilon Therapeutics Charts.

News Sigilon Therapeutics Inc

Form 15-12G - Securities registration termination [Section 12(g)]
Montag 21 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Mittwoch 16 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Lilly Completes Acquisition of Sigilon Therapeutics
Montag 14 August 2023 (9 Monate vor) • PR Newswire (US)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Freitag 11 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Freitag 11 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 11 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 11 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 11 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 11 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
Donnerstag 10 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 7 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
Dienstag 1 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Weitere Sigilon Therapeutics Inc News-Artikel

BNP Paribas (QX)

Energy Select Sector SPDR

Deutsche Telekom (QX)

Euro vs US Dollar

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen